The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans
Intranasal delivery provides a practical, noninvasive method of bypassing the blood-brain barrier (BBB) in order to deliver therapeutic agents to the brain.This method allows drugs that do not cross the BBB to be delivered to the central nervous system in a few minutes.With this technology, it will be possible to eliminate systemic administration a